Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Carlos Jimenez Chillon"'
Autor:
Claudia Núñez-Torrón Stock, Carlos Jiménez Chillón, Fernando Martín Moro, Juan Marquet Palomanes, Miguel Piris Villaespesa, Ernesto Roldán Santiago, Eulalia Rodríguez Martín, Anabelle Chinea Rodríguez, Valentín García Gutiérrez, Gemma Moreno Jiménez, Javier López Jiménez, Pilar Herrera Puente
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundThe measurement of minimal residual disease (MRD) by multiparametric flow cytometry (MFC) before hematopoietic stem cell transplantation (HSCT) in patients with acute myeloid leukemia (AML) is a powerful prognostic factor. The interaction o
Externí odkaz:
https://doaj.org/article/cb620b5c4434440786715a8ec57a949b
Autor:
José María Bellón, Alfredo Bermejo, Ana Villegas, Sandra Gomez Gomez Rojas, Luis Alonso, Gloria Perez Segura, Montserrat López Rubio, Carlos Soto, Cristina Seri, Javier Loscertales, Lucia Castilla, Ariana Ortuzar, Jesús Villarrubia, Patricia Font Lopez, Carolina Muñoz, Miguel Piris-Villaespesa, José Luis Díez-Martín, María Teresa Cedena, Mónica Ballesteros, Pilar Ricard, Carlos Jimenez Chillon, Celina Benavente
Publikováno v:
Blood. 138:2607-2607
Introduction. The boundaries between MDS and AML are still a matter of debate. In the 2001 WHO Classification, the myeloblast count distinguishing AML and MDS was lowered from 30% to 20% of the bone marrow (BM) cells or peripheral blood (PB) leukocyt
Autor:
Kyra Velázquez-Kennedy, Valentín García-Gutiérrez, Miguel Piris-Villaespesa, Javier Lopez Jimenez, Claudia Nunez-Torron, Alejandro Luna, Gemma Moreno Jiménez, Anabelle Chinea, Carlos Jimenez Chillon, Adolfo Saez, Juan Marquet Palomanes, Fernando Martin Moro, Pilar Herrera
Publikováno v:
Blood. 138:3931-3931
Introduction: Response to chemotherapy treatment both by cytology and by more sensitive techniques such as cytometry is one of the most influential parameters in the survival of patients with Acute Myeloid Leukaemia (AML). Patients with detectable mi
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.